TESSA TRAN: Open Payments
NPI 1114534070 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 34 payments from 13 companies in 2025. Trend: 2023 $476 · 2024 $613 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $185 |
| Amgen Inc. | 10 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $137 |
| ABBVIE INC. | 2 | $102 |
| Eisai Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| PFIZER INC. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: Ozempic, JARDIANCE, EVENITY, VRAYLAR, Leqembi, REXULTI, PREVNAR 20, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
